| ASSET | YEAR | % RETURN |
|---|---|---|
Summit Therapeutics (SMMT) | 2015 | 16.16% |
Summit Therapeutics (SMMT) | 2016 | -22.18% |
Summit Therapeutics (SMMT) | 2017 | 31.59% |
Summit Therapeutics (SMMT) | 2018 | -89.53% |
Summit Therapeutics (SMMT) | 2019 | 45.45% |
Summit Therapeutics (SMMT) | 2020 | 193.75% |
Summit Therapeutics (SMMT) | 2021 | -43.37% |
Summit Therapeutics (SMMT) | 2022 | 64.03% |
Summit Therapeutics (SMMT) | 2023 | -39.86% |
Summit Therapeutics (SMMT) | 2024 | 591.67% |
Summit Therapeutics (SMMT) | 2025 | -2.67% |
Summit Therapeutics (SMMT) | 2026 | -17.58% |